At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Osia 2 Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market.
In Brief
A clinical study evaluating Osia 2 System for Conductive Hearing Loss and Mixed Hearing Loss. Completed, enrolled 20 participants across 4 sites.
Detailed Summary
To evaluate the clinical efficacy of the Osia 2 system in patients with conductive or mixed conductive hearing loss in a US cohort.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConductive Hearing Loss, Mixed Hearing Loss
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMar 2020
Enrollment StartSep 2020
Primary CompletionOct 2021
Study CompletionDec 2021
TodayJul 2026
First PostedMar 25, 2020
Enrollment StartSep 30, 2020
Primary CompletionOct 5, 2021
Study CompletionDec 28, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.3 years ago
Interventions
Osia 2 Systemdevice
The external Sound Processor, Osia 2 Active Osseointegrated Implant System for Bone Conduction, captures and digitizes the sound which is transferred to the internal implant where it is converted to an electrical signal.